Cargando…

Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature

This Mini Review of the literature aimed to assess the role of tocilizumab for the treatment of severe coronavirus disease 2019 (COVID-19). Based on the available scientific evidence, it is not clear to date what is the best therapeutic strategy for the treatment of COVID-19. Since SARS-CoV-2 infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacca, Erica, Digaetano, Margherita, Meschiari, Marianna, Franceschini, Erica, Menozzi, Marianna, Cuomo, Gianluca, Mussini, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699161/ https://www.ncbi.nlm.nih.gov/pubmed/33303188 http://dx.doi.org/10.1016/j.bbrc.2020.11.084

Ejemplares similares

Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period
por: Franceschini, E., et al.
Publicado: (2020)

Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection
por: Cuomo, Gianluca, et al.
Publicado: (2020)

Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
por: Meschiari, Marianna, et al.
Publicado: (2020)

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria
por: Santoro, Antonella, et al.
Publicado: (2020)

Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?
por: Medioli, Filippo, et al.
Publicado: (2022)

Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
por: Franceschini, Erica, et al.
Publicado: (2021)

Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study
por: Meschiari, Marianna, et al.
Publicado: (2021)

1979. Five-Year Impact of an Antimicrobial Stewardship Program on Nosocomial Candidemia: An Interrupted Time-Series Analysis Study
por: Bedini, Andrea, et al.
Publicado: (2019)

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022)

Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
por: Milic, Jovana, et al.
Publicado: (2021)

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
por: Mussini, Cristina, et al.
Publicado: (2021)

The Impact of COVID-19 on UNAIDS 90–90–90 Targets: Calls for New HIV Care Models
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015–2021)
por: Meschiari, Marianna, et al.
Publicado: (2022)

Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature
por: Burastero, Giulia Jole, et al.
Publicado: (2022)

Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach
por: Puzzolante, Cinzia, et al.
Publicado: (2019)

Acid base disorders in patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients
por: Alfano, Gaetano, et al.
Publicado: (2021)

Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART
por: Franconi, Iacopo, et al.
Publicado: (2019)

Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
por: Gallerani, Altea, et al.
Publicado: (2023)

Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
por: Ferrari, Davide, et al.
Publicado: (2020)

Hypokalemia in Patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review
por: Dolci, Giovanni, et al.
Publicado: (2023)

A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review
por: Barp, Nicole, et al.
Publicado: (2023)

Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
por: Mussini, Cristina, et al.
Publicado: (2021)

Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab
por: Franceschini, Erica, et al.
Publicado: (2023)

Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial
por: Cossarizza, Andrea, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in patients with severe COVID-19: a retrospective cohort study
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome
por: Milic, Jovana, et al.
Publicado: (2022)

Re: ‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ by Wolkewitz et al.
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2021)

Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections
por: Meschiari, Marianna, et al.
Publicado: (2021)

Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
por: Zhang, Yinhua, et al.
Publicado: (2020)

A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit
por: Meschiari, Marianna, et al.
Publicado: (2021)

A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
por: Alteri, Claudia, et al.
Publicado: (2022)

Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
por: Caciagli, Valeria, et al.
Publicado: (2023)

Adherence to Lipid-Lowering Medication in People Living with HIV: An Outpatient Clinic Drug Direct Distribution Experience
por: Cuomo, Gianluca, et al.
Publicado: (2021)

First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report
por: Barp, Nicole, et al.
Publicado: (2022)

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)
por: Bartoletti, Michele, et al.
Publicado: (2020)

Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs
por: Meschiari, Marianna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v2615gpv4d9eiqc6rg8at5drcu